H-L-Tyr-NH2*HCl

H-L-Tyr-NH2*HCl is a stereodefined amino acid derivative corresponding to L-tyrosine bearing a primary amino group at the carboxyl-terminus, presented as the hydrochloride salt. The molecule contains a phenolic side chain on the aromatic ring, a chiral alpha-carbon typical of L-amino acid frameworks, and an overall salt-forming basic amine that improves handling and aqueous compatibility for downstream coupling chemistry. The phenolic hydroxyl enables selective derivatization for protecting-group strategies and conjugation handles, while the amino functionality supports formation of amide and urea linkages under standard peptide and heterocycle-forming conditions. As an amino acid amide/amine building block, H-L-Tyr-NH2*HCl functions as a chemically defined precursor for peptide construction, side-chain functionalization, and chiral intermediate preparation in both research and process-oriented synthetic routes.

1. Peptide Synthesis

H-L-Tyr-NH2*HCl is used in peptide synthesis workflows where an amino acid amide-forming terminus is required for C-terminal incorporation. The L-tyrosine backbone provides the stereogenic center for stereochemically consistent coupling, while the phenolic hydroxyl can be protected or selectively functionalized to avoid side reactions during amide bond formation. The hydrochloride salt form supports controlled reactivity of the terminal amino group during coupling and can be paired with orthogonal protection strategies for the phenol to enable stepwise assembly. Downstream peptide analogs prepared from H-L-Tyr-NH2*HCl can include tyrosine-containing sequences used for biochemical assays, reference standards, and structure-activity relationship studies that depend on defined C-terminal functionality.

2. Side-Chain Functionalization

H-L-Tyr-NH2*HCl serves as a key substrate for tyrosine side-chain modification in chemical biology and synthetic organic chemistry. The phenolic hydroxyl enables transformation into protected phenols, activated leaving groups, or conjugation-ready derivatives, while the terminal amino group supports conversion into ureas, amides, and other nitrogen-containing linkages. The salt-stabilized amine can be deprotonated under controlled conditions to participate in derivatization steps that preserve the L-configuration at the alpha-carbon. Functionalized tyrosine derivatives derived from H-L-Tyr-NH2*HCl can be used to generate molecular probes, enzyme-binding motifs, and peptidomimetic scaffolds where aromatic phenol chemistry is required for specific recognition or further synthetic elaboration.

3. Chemical Biology Probes

H-L-Tyr-NH2*HCl is applied in chemical biology for constructing tyrosine-based molecular probes and recognition elements. The aromatic phenolic group can be leveraged for site-specific labeling chemistries or for tuning hydrogen-bonding and aromatic interaction patterns in probe design. The terminal amino group at the carboxyl-terminus provides a handle for forming stable linkages to carriers, tags, or scaffold backbones, supporting the generation of defined amino acid conjugates. Use of H-L-Tyr-NH2*HCl in probe synthesis aligns with amino acid derivatization strategies that require stereochemical fidelity and functional-group compatibility across multiple synthetic steps.

4. Bioconjugation Chemistry

H-L-Tyr-NH2*HCl supports bioconjugation and biomolecule modification where tyrosine-derived motifs are incorporated into tagged constructs. The phenolic hydroxyl can be protected to maintain chemoselectivity during conjugation, then deprotected or transformed to introduce reactive groups for coupling to proteins, peptides, or polymeric carriers. The hydrochloride salt form helps manage amino group protonation state, which can be important for reproducible coupling behavior in multi-component manufacturing or lab-scale synthesis. Conjugates prepared from H-L-Tyr-NH2*HCl can be used as analytical reagents, calibration materials, or component intermediates for downstream labeling and binding assays that rely on defined amino acid composition and terminal functionality.

5. Pharmaceutical Intermediate Preparation

H-L-Tyr-NH2*HCl is suitable for pharmaceutical intermediate preparation in fine chemical synthesis and process chemistry contexts that require a chiral tyrosine-derived nitrogen functionality. The L-tyrosine stereocenter enables incorporation into larger chiral frameworks, while the phenolic hydroxyl can be temporarily masked to control chemoselectivity and later reintroduced or transformed for medicinal chemistry elaboration. The terminal amino group can participate in forming amide, urea, or related nitrogen-containing intermediates used to build heterocyclic cores or side-chain substituted scaffolds. Downstream synthetic use of H-L-Tyr-NH2*HCl includes preparation of well-defined chiral building blocks for SAR studies and manufacturing routes where reproducible functional-group handling is required.

6. Analytical Research Standards

H-L-Tyr-NH2*HCl is used in analytical research as a defined amino acid derivative standard for method development and characterization of tyrosine-containing products. The combination of a stereodefined L-configuration, a phenolic hydroxyl, and a terminal amino functionality enables consistent chromatographic and spectrometric behavior relative to related tyrosine derivatives. The hydrochloride salt form can improve solubility and reproducibility in analytical workflows that require accurate mass-based identification and calibration. Reference materials derived from H-L-Tyr-NH2*HCl support impurity profiling, identity confirmation, and structural verification in peptide building block preparation and amino acid derivatization studies.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. The spatiotemporal control of signalling and trafficking of the GLP-1R